Your browser doesn't support javascript.
loading
Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study.
Gorgojo-Martinez, Juan J; Ferreira-Ocampo, Pablo José; Galdón Sanz-Pastor, Alba; Cárdenas-Salas, Jersy; Antón-Bravo, Teresa; Brito-Sanfiel, Miguel; Almodóvar-Ruiz, Francisca.
Afiliação
  • Gorgojo-Martinez JJ; Department of Endocrinology and Nutrition, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain.
  • Ferreira-Ocampo PJ; Department of Endocrinology and Nutrition, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain.
  • Galdón Sanz-Pastor A; Department of Endocrinology and Nutrition, Hospital Universitario Gregorio Marañón, 28007 Madrid, Spain.
  • Cárdenas-Salas J; Department of Endocrinology and Nutrition, Fundación Jiménez Díaz, 28040 Madrid, Spain.
  • Antón-Bravo T; Department of Endocrinology and Nutrition, Hospital Universitario de Móstoles, 28935 Madrid, Spain.
  • Brito-Sanfiel M; Department of Endocrinology and Nutrition, Hospital Universitario Puerta de Hierro, 28222 Madrid, Spain.
  • Almodóvar-Ruiz F; Department of Endocrinology and Nutrition, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain.
J Clin Med ; 12(13)2023 Jun 25.
Article em En | MEDLINE | ID: mdl-37445283

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article